These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 8573142

  • 1. Analysis of p16INK4a and its interaction with CDK4.
    Yang R, Serrano M, Slater J, Leung E, Koeffler HP.
    Biochem Biophys Res Commun; 1996 Jan 05; 218(1):254-9. PubMed ID: 8573142
    [Abstract] [Full Text] [Related]

  • 2. Direct binding of the N-terminus of HTLV-1 tax oncoprotein to cyclin-dependent kinase 4 is a dominant path to stimulate the kinase activity.
    Li J, Li H, Tsai MD.
    Biochemistry; 2003 Jun 10; 42(22):6921-8. PubMed ID: 12779347
    [Abstract] [Full Text] [Related]

  • 3. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16Ink4a and counteracts its inhibitory activity to CDK4.
    Suzuki T, Yoshida M.
    Leukemia; 1997 Apr 10; 11 Suppl 3():14-6. PubMed ID: 9209282
    [Abstract] [Full Text] [Related]

  • 4. Mutational effects on the p16INK4a tumor suppressor protein.
    Yang R, Gombart AF, Serrano M, Koeffler HP.
    Cancer Res; 1995 Jun 15; 55(12):2503-6. PubMed ID: 7780957
    [Abstract] [Full Text] [Related]

  • 5. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
    Noh SJ, Li Y, Xiong Y, Guan KL.
    Cancer Res; 1999 Feb 01; 59(3):558-64. PubMed ID: 9973200
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R, Laín S, Ball KL, Lane DP.
    Oncogene; 1998 Feb 05; 16(5):587-96. PubMed ID: 9482104
    [Abstract] [Full Text] [Related]

  • 7. Several noncontiguous domains of CDK4 are involved in binding to the P16 tumor suppressor protein.
    Ceha HM, Nasser I, Medema RH, Slebos RJ.
    Biochem Biophys Res Commun; 1998 Aug 19; 249(2):550-5. PubMed ID: 9712735
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE, Xiong Y.
    Cell Growth Differ; 1998 Aug 19; 9(8):595-610. PubMed ID: 9716177
    [Abstract] [Full Text] [Related]

  • 12. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.
    Russo AA, Tong L, Lee JO, Jeffrey PD, Pavletich NP.
    Nature; 1998 Sep 17; 395(6699):237-43. PubMed ID: 9751050
    [Abstract] [Full Text] [Related]

  • 13. The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner.
    Li J, Melvin WS, Tsai MD, Muscarella P.
    Biochemistry; 2004 Apr 13; 43(14):4394-9. PubMed ID: 15065884
    [Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J, Akusjärvi G, Goike HM, Roos G, Collins VP, Pettersson RF.
    Cell Growth Differ; 2000 Jul 13; 11(7):373-84. PubMed ID: 10939591
    [Abstract] [Full Text] [Related]

  • 15. Structure of the cyclin-dependent kinase inhibitor p19Ink4d.
    Luh FY, Archer SJ, Domaille PJ, Smith BO, Owen D, Brotherton DH, Raine AR, Xu X, Brizuela L, Brenner SL, Laue ED.
    Nature; 1997 Oct 30; 389(6654):999-1003. PubMed ID: 9353127
    [Abstract] [Full Text] [Related]

  • 16. Identification of CDK4 sequences involved in cyclin D1 and p16 binding.
    Coleman KG, Wautlet BS, Morrissey D, Mulheron J, Sedman SA, Brinkley P, Price S, Webster KR.
    J Biol Chem; 1997 Jul 25; 272(30):18869-74. PubMed ID: 9228064
    [Abstract] [Full Text] [Related]

  • 17. p16 proteins from melanoma-prone families are deficient in binding to Cdk4.
    Reymond A, Brent R.
    Oncogene; 1995 Sep 21; 11(6):1173-8. PubMed ID: 7566978
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.